GBT - Global Blood Therapeutics GAAP EPS of -$1.26 misses by $0.08 revenue of $71.55M beats by $7.16M
- Global Blood Therapeutics press release ( NASDAQ: GBT ): Q2 GAAP EPS of -$1.26 misses by $0.08 .
- Revenue of $71.55M (+50.4% Y/Y) beats by $7.16M .
- Cash and cash equivalents of $261.15M
For further details see:
Global Blood Therapeutics GAAP EPS of -$1.26 misses by $0.08, revenue of $71.55M beats by $7.16M